Gene · 7277
Papers2,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative interactome mapping of Tau-protein in classical and rapidly progressive Alzheimer's disease identifies subtype-specific pathways. | Neuropathol Appl Neurobiol | 2024 | 38374702 | PubTator, text mining | PubMed |
| Being there and being with them: the effects of visibility affordance of online short fitness video on users' intention to cloud fitness. | Front Psychol | 2024 | 38362244 | PubTator, text mining | PubMed |
| Social visibility of consumption and conspicuous consumption: An empirical analysis of Chinese wedding ceremonies. | Heliyon | 2024 | 38356553 | PubTator, text mining | PubMed |
| Paradox mindset as an equalizer: A moderated mediated perspective on workplace ostracism. | PLoS One | 2024 | 38324580 | PubTator, text mining | PubMed |
| Research on the formation mechanism of brand identification in cross-border e-commerce platforms - Based on the perspective of perceived brand globalness/localness. | Heliyon | 2024 | 38322856 | PubTator, text mining | PubMed |
| Enhancing tourist loyalty through location-based service apps: Exploring the roles of digital literacy, perceived ease of use, perceived autonomy, virtual-content congruency, and tourist engagement. | PLoS One | 2024 | 38295124 | PubTator, text mining | PubMed |
| Authenticity: Effective emotional labor strategies on teaching efficacy of university teachers in China. | PLoS One | 2024 | 38277428 | PubTator, text mining | PubMed |
| When and how scientists influence technological performance: A moderated mediation model. | PLoS One | 2024 | 38271452 | PubTator, text mining | PubMed |
| Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome. | Biomedicines | 2024 | 38255234 | PubTator, text mining | PubMed |
| Sustaining the future: How green capabilities and digitalization drive sustainability in modern business. | Heliyon | 2024 | 38234898 | PubTator, text mining | PubMed |
| Cu-Catalyzed Azide-Alkyne-Thiol Reaction Forms Ubiquitous Background in Chemical Proteomic Studies. | J Am Chem Soc | 2024 | 38214237 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell and bulk RNA-sequencing data revealed T cell marker genes based molecular sub-types and a prognostic signature in lung adenocarcinoma. | Sci Rep | 2024 | 38200058 | PubTator, text mining | PubMed |
| Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease. | Cell Death Dis | 2024 | 38177100 | PubTator, text mining | PubMed |
| Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. | J Extracell Vesicles | 2024 | 38173127 | PubTator, text mining | PubMed |
| Examining double standards in layoff preferences and expectations for gender, age, and ethnicity when violating the social norm of vaccination. | Sci Rep | 2024 | 38167903 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Analysis of Microglia Dissected the Energy Metabolism and Revealed Potential Biomarkers in Amyotrophic Lateral Sclerosis. | Mol Neurobiol | 2024 | 38102515 | PubTator, text mining | PubMed |
| Epigenetic modifications: Key players in cancer heterogeneity and drug resistance. | Transl Oncol | 2024 | 37931371 | PubTator, text mining | PubMed |
| Strategies for translating proteomics discoveries into drug discovery for dementia. | Neural Regen Res | 2024 | 37488854 | PubTator, text mining | PubMed |
| Indicators of trustworthiness in lay-friendly research summaries: Scientificness surpasses easiness. | Public Underst Sci | 2024 | 37278009 | PubTator, text mining | PubMed |
| Sunk Cost Effects for Time Versus Money: Replication and Extensions Registered Report of Soman (). | Int Rev Soc Psychol | 2023 | 40951812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7277/papers?page=9